Noster Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

KYOTO, Japan, Nov. 27, 2023 /PRNewswire/ -- In a study recently published in the journal Scientific Reports, researchers from Shizuoka University, Noster Inc, and other groups in Japan identify gut-bacteria derived metabolites that can mitigate fatty liver disease. Nonalcoholic fatty liver disease (NAFLD) is a chronic liver condition that affects a sizable population of the developed world. Causes of NAFLD are stress, genetic predispositions, and preexisting conditions such as obesity. NAFLD is

NOSTER Inc and Science, the prestigious academic journal, joined forces to host the NOSTER and Science Microbiome Prize Symposium and the 4th prize award ceremony on October 5th and 6th in Kyoto, Japan. The events brought together leading scientists and experts from around the globe to recognize and celebrate grand prize winner Sara Clasen of the Max Planck Institute for Biology, as well as finalists Christoph A. Thaiss, University of Pennsylvania, and Christopher Stewart, University of Newcastl

KOBE, Japan, Dec. 9, 2022 In a study recently published in the journal Hypertension, researchers from Kobe University and Noster Inc. report the role of gut...

Kobe University research: Healthy gut, healthy heart: Gut bacteria and heart disease PR Newswire KOBE, Japan, Dec. 9, 2022 KOBE, Japan, Dec. 9, 2022 In a study recently

KYOTO, Japan, Dec. 2, 2022 /PRNewswire/ -- Researchers at Noster Inc. report in Medical Mass Spectrometry a method for the efficient quantification of a set of biomolecules produced by gut bacteria